Dr. Barry M. Uhl, MD

Dr. Uhl practices at Sharp Grossmont Hospital in La Mesa, California, part of Sharp HealthCare.

Dr. Uhl's NPI, 1811936693, was assigned on June 6, 2006. Dr. Uhl graduated from UNMC in 1995. Dr. Uhl holds California license A71969.

Dr. Uhl's primary practice is Sharp Grossmont Hospital, at 5555 Grossmont Center Drive Box 58, La Mesa, CA 91942 in San Diego County. The practice phone is (619) 465-0711.

Dr. Uhl's primary practice is Sharp Grossmont Hospital in La Mesa, California, part of Sharp HealthCare. Dr. Uhl is also affiliated with Sharp Chula Vista Medical Center. The medical group on file is X-Ray Medical Group, Inc. Dmand AI also links Dr. Uhl to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Uhl practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Uhl's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Uhl is board certified in radiation oncology by the American Board of Radiology. Dr. Uhl is licensed in California.

Dmand AI lists bladder cancer radiation, bone cancer radiation, brain cancer radiation, breast cancer radiation, cancer radiation-upper GI, colorectal cancer radiation, head & neck cancer radiation and lung cancer radiation among the conditions Dr. Uhl treats.

CMS data shows 1,878 Medicare services from Dr. Uhl across 17 procedure codes in 2024, for 228 Medicare patients. Medicare paid $140,497 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 228 Medicare patients who saw Dr. Uhl in 2024. The largest group is 65 to 74, with 110 patients. 75% of them have cancer, and 75% have high blood pressure. 25% are also on Medicaid. Their average risk score is 1.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Uhl's median patient age at 72, with 31% women.

In 2024, Dr. Uhl wrote 82 Medicare Part D claims for 33 patients. 100% of them were for generic drugs. CMS names the drug for 56 of them, across 1 drug with 11 or more claims each, at $403 in total drug cost. In 2023, CMS named 57 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 35 out of 100 for Dr. Uhl for performance year 2024, reported individually. Dr. Uhl accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Uhl. The most frequent topics are Prostatic Neoplasms, Radiotherapy, Conformal and Radiotherapy Dosage. Dr. Uhl has published most often in Int J Radiat Oncol Biol Phys. Dr. Uhl's most frequent co-authors are Bin Sing Teh, MD, Mark Emerson Augspurger, MD and Michael David Bastasch, MD.

CMS Open Payments shows 400 general payments to Dr. Uhl from 76 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $973.

Dr. Uhl graduated from UNMC in 1995.

Dr. Uhl is in network with 13 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.